RETRACTED: A glycolytic mechanism regulating an angiogenic switch in prostate cancer (Retracted article. See vol. 81, pg. 1623, 2021)

被引:120
作者
Wang, Jianhua
Wang, Jincheng
Dai, Jinlu
Jung, Younghun
Wei, Chuen-Long
Wang, Yu
Havens, Aaron M.
Hogg, Phillip J.
Keller, Evan T.
Pienta, Kenneth J.
Nor, Jacques E.
Wang, Cun-Yu
Taichman, Russell S.
机构
[1] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Dent, Dept Cariol Restorat Sci & Endodont, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Sch Dent, Div Prosthodont, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA
[5] Univ Michigan, Sch Med, Div Internal Med & Urol, Ann Arbor, MI 48109 USA
[6] Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia
关键词
D O I
10.1158/0008-5472.CAN-06-2971
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The generation of an 'angiogenic switch' is essential for tumor growth, yet its regulation is poorly understood. In this investigation, we explored the linkage between metastasis and angiogenesis through CXCL12/CXCR4 signaling. We found that CXCR4 regulates the expression and secretion of the glycolytic enzyme phosphoglycerate kinase 1 (PGK1). Overexpression of PGK1 reduced the secretion of vascular endothelial growth factor and interleukin-8 and increased the generation of angiostatin. At metastatic sites, however, high levels of CXCL12 signaling through CXCR4 reduced PGK1 expression, releasing the angiogenic response for metastastic growth. These data suggest that PGK1 is a critical downstream target of the chemokine axis and an important regulator of an 'angiogenic switch' that is essential for tumor and metastatic growth.
引用
收藏
页码:149 / 159
页数:11
相关论文
共 31 条
[1]   Protein profiles associated with survival in lung adenocarcinoma [J].
Chen, GA ;
Gharib, TG ;
Wang, H ;
Huang, CC ;
Kuick, R ;
Thomas, DG ;
Shedden, KA ;
Misek, DE ;
Taylor, JMG ;
Giordano, TJ ;
Kardia, SLR ;
Iannettoni, MD ;
Yee, J ;
Hogg, PJ ;
Orringer, MB ;
Hanash, SM ;
Beer, DG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (23) :13537-13542
[2]   Secretion of phosphoglycerate kinase from tumour cells is controlled by oxygen-sensing hydroxylases [J].
Daly, EB ;
Wind, T ;
Jiang, XM ;
Sun, L ;
Hogg, PJ .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2004, 1691 (01) :17-22
[3]   Seeking a home for a PET, Part 2 - Defining the appropriate place for positron emission tomography imaging in the staging of patients with suspected lung cancer [J].
Detterbeck, FC ;
Falen, S ;
Rivera, MP ;
Halle, JS ;
Socinski, MA .
CHEST, 2004, 125 (06) :2300-2308
[4]   CD44 potentiates the adherence of metastatic prostate and breast cancer cells to bone marrow endothelial cells [J].
Draffin, JE ;
McFarlane, S ;
Hill, A ;
Johnston, PG ;
Waugh, DJJ .
CANCER RESEARCH, 2004, 64 (16) :5702-5711
[5]   The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis [J].
Havens, A. M. ;
Jung, Y. ;
Sun, Y. X. ;
Wang, J. ;
Shah, R. B. ;
Buhring, H. J. ;
Pienta, K. J. ;
Taichman, R. S. .
BMC CANCER, 2006, 6 (1)
[6]   Overexpression and elevated serum levels of phosphoglycerate kinase 1 in pancreatic ductal adenocarcinoma [J].
Hwang, TL ;
Liang, Y ;
Chien, KY ;
Yu, JS .
PROTEOMICS, 2006, 6 (07) :2259-2272
[7]   Vascular endothelial growth factor contributes to prostate cancer-mediated osteoblastic activity [J].
Kitagawa, Y ;
Dai, JL ;
Zhang, J ;
Keller, JM ;
Nor, J ;
Yao, Z ;
Keller, ET .
CANCER RESEARCH, 2005, 65 (23) :10921-10929
[8]  
LaTulippe E, 2002, CANCER RES, V62, P4499
[9]   Phosphoglycerate kinase acts in tumour angiogenesis as a disulphide reductase [J].
Lay, AJ ;
Jiang, XM ;
Kisker, O ;
Flynn, E ;
Underwood, A ;
Condron, R ;
Hogg, PJ .
NATURE, 2000, 408 (6814) :869-873
[10]   Interleukin-8 confers androgen-independent growth and migration of LNCaP: differential effects of tyrosine kinases Src and FAK [J].
Lee, LF ;
Louie, MC ;
Desai, SJ ;
Yang, J ;
Chen, HW ;
Evans, CP ;
Kung, HJ .
ONCOGENE, 2004, 23 (12) :2197-2205